L'un des principaux objectifs de Life4me + - est de prévenir de nouveaux cas de VIH et d'autres IST, d'hépatite C et de tuberculose.

L'application aide à établir une communication anonyme entre les médecins et les personnes séropositives. Elle vous permet d'organiser facilement votre horaire de prise de médicaments et de définir des rappels cachés et personnalisés.

Toutes les actualités

Archive

✕

21 mars 2018

7115

Cats can aid development of antiviral drugs for people living with HIV

Cats can aid development of antiviral drugs for people living with HIV

HIV and the feline immunodeficiency virus (FIV) are similar in structure and action, but the latter has features that allow it to be resistant to certain HIV drugs. This phenomenon of resistance has been studied by scientists in order to develop a drug for multidrug-resistant ...

20 mars 2018

6850

The rate of HIV spread in Russia reached a maximum

The rate of HIV spread in Russia reached a maximum

According to the Ministry of Health, 88,600 new HIV cases were registered 2017 in Russia, and according to the other Russian authority Rospotrebnadzor (ed. “authority of epidemiology”), 104,400 cases. The difference between the two authorities was always present, since they ...

15 mars 2018

6121

A step forward to the vaccine against HIV

A step forward to the vaccine against HIV

Science is moving forward, and scientists are coming closer to the solution of the mystery of the 21st century - the vaccine against HIV. This time they modified the antibodies and increased their ability to neutralize HIV-1. New modified Tri-NAb antibodies are now capable ...

14 mars 2018

6327

Powerful new PrEP and treatment drug should be effective as a small weekly pill

Powerful new PrEP and treatment drug should be effective as a small weekly pill

MK-8591 to be taken into HIV treatment trials with another new drug, doravirine.

13 mars 2018

7397

Rapid testing of HIV and HBC/HVC in Portugal

Rapid testing of HIV and HBC/HVC in Portugal

On March 12, 2018, the Portuguese government authorized rapid testing for HIV and hepatitis B and C in pharmacies and laboratories without a doctor's prescription, according to the Ministry of Health. The decision will come into force 30 days after signing.

13 mars 2018

5983

Naltrexone helps ex-prisoners with substance use disorders succeed on HIV meds

Naltrexone helps ex-prisoners with substance use disorders succeed on HIV meds

Monthly injections of extended-release naltrexone is linked to viral suppression among this population. CROI2018

12 mars 2018

4757

Mutated subtype of HIV from the Philippines threatens with a new outbreak of the epidemic

Mutated subtype of HIV from the Philippines threatens with a new outbreak of the epidemic

"We have discovered that the explosion of HIV in the Philippines is due to a shift from the Western subtype B to a more aggressive HIV subtype AE. Those infected by the HIV subtype AE are younger, sicker patients who are more resistant to antiretroviral (ARV) drugs. We are ...

11 mars 2018

8855

Matthew Hodson: "PrEP is more effective than condoms"

Matthew Hodson: "PrEP is more effective than condoms"

Recently, pre-exposure prophylaxis of HIV (PrEP) is gaining momentum and is becoming one of the most popular strategies for reducing new HIV transmission. However, isolated cases of PrEP failures put it under attack. Matthew Hodson, a British expert on advocacy of people ...

10 mars 2018

4225

Find and destroy. Where and how is HIV concealed and why is it so important to catch it from there

Find and destroy. Where and how is HIV concealed and why is it so important to catch it from there

The human immunodeficiency virus is known to have a secret life. Modern ART can suppress the reproduction of the virus in the body, bringing the viral load to zero, but it cannot "purify" the body from HIV completely. Virus sits in "hidden reservoirs" and becomes invisible ...

10 mars 2018

4498

In the United States a new drug for HIV with multidrug-resistant was approved

In the United States a new drug for HIV with multidrug-resistant was approved

During the Conference on Retroviruses and Opportunistic Infections (CROI2018) in Boston the US Food and Drug Administration (FDA) announced that it has approved ibalizumab-uiyk, to be marketed as Trogarzo, for people with HIV who have limited options due to extensive prior ...

1...23 24 25 26 27...100